Elevance Health, Inc.

Elevance Health, Inc. (ELV) — Form 144: Proposed sale of shares

144ELVFiled Nov 5, 2026, 4:13 PM ET

AI-generated summary

Officer RATNAKAR LAVU proposed to sell 1,300 common shares of Elevance Health, Inc. with an aggregate market value of $572,000 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through restricted stock on March 1, 2026 and March 1, 2025. The approximate sale date is November 5, 2026.

View original filing on SEC.gov

Key facts

Seller: RATNAKAR LAVU
Relationship: Officer
Shares to sell: 1,300
Market value: $572,000.00
Approximate sale date: Nov 5, 2026
Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired (1): Mar 1, 2026 · Restricted Stock
Acquired (2): Mar 1, 2025 · Restricted Stock

More ELV filings

S-3ASR
SEC filing
Filed Oct 28, 2026
4
Insider transaction
Filed Oct 23, 2026
144
Proposed sale of shares
Filed Oct 22, 2026
10-Q
Quarterly report
Filed Oct 21, 2026
8-K
Current report
Filed Oct 21, 2026
4
Insider transaction
Filed Oct 6, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.